Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBionomics Limite Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Bionomics Limite Earnings Date And Information
Bionomics Limite last posted its earnings results on Monday, September 30th, 2024. The company reported $-212.07582 earnings per share for the quarter, missing analysts' consensus estimates of $-0.9483 by $211.12752. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Bionomics Limite has generated $-41 earnings per share over the last year ($-41.4 diluted earnings per share) and currently has a price-to-earnings ratio of -0.42. Bionomics Limite has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Bionomics Limite Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/15/2026 | Q3 2025 | N/A | -$16.20 | N/A | N/A | $0 |
| 02/17/2026 | Q2 2025 | N/A | $73.80 | N/A | N/A | $0 |
| 11/14/2025 | Q1 2025 | N/A | -$793.80 | N/A | N/A | $0 |
| 09/29/2025 | Q4 2024 | N/A | -$3.83 | N/A | N/A | $-15,662,715 |
| 05/20/2025 | Q3 2024 | N/A | $189.00 | N/A | N/A | $15.00 M |
| 02/14/2025 | Q2 2024 | N/A | -$221.40 | N/A | N/A | $662.72 K |
| 11/14/2024 | Q1 2024 | N/A | -$5.17 | N/A | N/A | $0 |
| 09/30/2024 | Q4 2023 | -$0.95 | -$1.80 | -0.85 | $1.77 M | $-165,593 |
| 10/01/2024 | Q2 2023 | N/A | -$246.60 | N/A | N/A | $72.49 K |
| 09/29/2023 | Q1 2023 | N/A | -$145.80 | N/A | N/A | $72.87 K |
| 10/01/2024 | Q4 2022 | N/A | -$351.00 | N/A | N/A | $22.42 K |
| 03/31/2023 | Q3 2022 | N/A | -$100.80 | N/A | N/A | $172.76 K |
| 10/01/2024 | Q2 2022 | N/A | -$351.00 | N/A | N/A | $-213,173 |
| 10/06/2022 | Q1 2022 | N/A | -$135.00 | N/A | N/A | $65.62 K |
| 10/14/2022 | Q4 2021 | N/A | -$217.80 | N/A | N/A | $275.43 K |
| 03/31/2022 | Q3 2021 | N/A | -$61.20 | N/A | N/A | $2.20 M |
| 12/29/2021 | Q2 2021 | N/A | -$325.80 | N/A | N/A | $84.88 K |
| 09/30/2021 | Q1 2021 | N/A | -$153.00 | N/A | N/A | $61.20 K |
| 10/01/2024 | Q4 2020 | N/A | -$138.60 | N/A | N/A | $161.41 K |
| 03/31/2021 | Q3 2020 | N/A | -$106.20 | N/A | N/A | $122.68 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bionomics Limite Earnings: FAQ's
The conference call for Bionomics Limite's latest earnings report can be listened to online.
The conference call transcript for Bionomics Limite's latest earnings report can be read online.
Bionomics Limite (:BNOX) has a recorded net income of $-369,632,000.Bionomics Limite has generated $-41.4 earnings per share over the last four quarters.
Bionomics Limite (:BNOX) has a price-to-earnings ratio of -0.42 and price/earnings-to-growth ratio is 0.01.